Granted Patent
B2
US 12,465,625 · App. 18/219,412 · Granted Nov 11, 2025
Maca compositions and methods of use
Assignee:
Bonafide Health, LLC
View Patent ↗
Loading inventors, assignments & file history…
Abstract
The present application is directed to composition comprising various maca extracts and the use of such compositions for treating certain diseases, disorders, and conditions.
Claims (10)
1 . A method of improving mitochondrial function in cells in a subject in need thereof comprising administering a nutritional supplement to the subject, wherein the nutritional supplement comprises an effective amount of a maca composition ( Lepidium meyenii ) comprising a synergistic combination consisting of black maca and red maca in a ratio of 4:1; and wherein the maca composition has between about 200 mg and about 700 mg of total glucosinolates per 100 grams of the maca composition.
2 . The method of claim 1 , wherein the maca composition has between about 250 mg and about 450 mg of total polyphenols per 100 grams of the maca composition.
3 . The method of claim 1 , wherein the maca composition has between about 15 grams and about 40 grams of total sugar per 100 grams of the maca composition.
4 . The method of claim 1 , wherein the maca composition has between about 10 grams and about 15 grams of protein per 100 grams of the maca composition.
5 . The method of claim 1 , wherein the maca composition has between about 9000 mg and about 12000 mg of total amino acids per 100 grams of the maca composition.
6 . The method of claim 1 , wherein the nutritional supplement has a pH of less than 5.4.
7 . The method of claim 1 , wherein the maca composition has between about 0.3 grams and about 0.8 grams of free fatty acids as oleic acid per 100 grams of the maca composition.
8 . The method of claim 1 , wherein the maca composition has between about 0.2 μmol and about 0.35 μmol of glucoalyssin per gram of the maca composition.
9 . The method of claim 1 , wherein the maca composition has between about 0.2 μmol and about 0.5 μmol of 4-hydroxyglucobrassicin per gram of the maca composition.
10 . The method of claim 1 , wherein the maca composition has between about 5 μmol and about 13 μmol of gluctoropaeolin per gram of the maca composition.
Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Sep 29, 2023
From: JDS THERAPEUTICS, LLC
To: BONAFIDE HEALTH, LLC
Reel/Frame 065072/0787 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Jul 7, 2023
From: KOMOROWSKI, JAMES R.; OJALVO, SARA PEREZ
To: JDS THERAPEUTICS, LLC
Reel/Frame 064187/0289 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Jul 7, 2023
From: JDS THERAPEUTICS, LLC
To: NUTRITION 21, LLC
Reel/Frame 064187/0347 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Jul 7, 2023
From: NUTRITION 21, LLC
To: JDS THERAPEUTICS, LLC
Reel/Frame 064187/0369 →
Continuity (4)
Provisional Application
62411977
· Oct 24, 2016
References Cited (91)
US 5942220A
· Warren et al.
· 1999
[cited by applicant]
US 7985434B2
· Gonzales Rengifo et al.
· 2011
[cited by applicant]
US 20040137131A1
· Bobrowski
· 2004
[cited by applicant]
US 20060147600A1
· Gonzales et al.
· 2006
[cited by applicant]
US 20090280203A1
· Gonzales Rengifo et al.
· 2009
[cited by applicant]
US 20130177513A1
· Saunois et al.
· 2013
[cited by applicant]
US 20180110817A1
· Komorowski et al.
· 2018
[cited by applicant]
US 20180110818A1
· Komorowski et al.
· 2018
[cited by applicant]
US 20180369310A1
· Komorowski et al.
· 2018
[cited by applicant]
CN 105367677
· 2016
[cited by applicant]
EP 2481300
· 2012
[cited by applicant]
JP 2008237117
· 2008
[cited by applicant]
WO WO2018081183
· 2018
[cited by applicant]
Chen et al., “Macamides present in the commercial maca (
[cited by applicant]
Gonzales et al., “Role of maca (
[cited by applicant]
Meissner et al., Short and long-term physiological responses of male and female rats to two dietary levels of pre-gelatinized maca (lepidium peruvianum chacon),0, International Journal of Biomedical Science, 2006; 2(1):…
[cited by applicant]
Wang et al., “Chemical composition and health effects of maca (Lepidium meyenii),” Food Chemistry, 2019; 288: pp. 422-443.
[cited by applicant]
Wang et al., “Maca: An Andean crop with multi-pharmacological functions,” Food Research International, 2007; 40(7): pp. 783-792.
[cited by applicant]
Alzamora et al., “Effect of four ecotypes of
[cited by applicant]
Bai et al., “Flavonolignans and Other Constituents from
[cited by applicant]
Benson et al., “Antioxidant, anti-inflammatory, anti-apoptotic, and skin regenerative properties of an Aloe vera-based extract of Nerium oleander leaves (NAE-8(®)” Clin Cosmet Investig Dermatol. 2015; 8: pp. 239-248.
[cited by applicant]
Benson et al., “West African
[cited by applicant]
Bianchi, “Maca
[cited by applicant]
Brooks et al., “Beneficial effects of Lepidium meyenii (Maca) on psychological symptoms and measures of sexual dysfunction in postmenopausal women are not related to estrogen or androgen content,” Menopause: The Journal…
[cited by applicant]
Carrión et al., “Antioxidant Activity of Three Ecotypes of Maca (
[cited by applicant]
Chen et al., “The Nutritional Composition of Maca in Hypocotyls (
[cited by applicant]
Clement et al., “Secondary Metabolites in Maca as Affected by Hypocotyl Color, Cultivation History, and Site”, Agronomy Journal, 2010; 102(2): pp. 431-439.
[cited by applicant]
Clément et al., “Effect of maca supplementation on bovine sperm quantity and quality followed over two spermatogenic cycles,” Theriogenology, 2010; 74(2): pp. 173-183.
[cited by applicant]
Clément et al., “Influence of colour type and previous cultivation on secondary metabolites in hypocotyls and leaves of maca (lepidium meyenii Walpers),” Journal of the Science of Food and Agriculture; 2010; 90(5): pp. …
[cited by applicant]
Dai Shengbo,
[cited by applicant]
DI Huijun,
[cited by applicant]
Dini et al.,“Chemical composition of
[cited by applicant]
Gasco et al., “ Effect of chronic treatment with three varieties of
[cited by applicant]
Gasco, “Dose-response effect of red maca (
[cited by applicant]
Gonzales et al., “Effect of short-term and long-term treatments with three ecotypes of Lepidium meyenii (MACA) on spermatogenesis in rats,” J. Enthnopharmacol., 2006, 3(20): pp. 448-454.
[cited by applicant]
Gonzales et al., “Effects of Different Varieties of Maca (
[cited by applicant]
Gonzales et al., “
[cited by applicant]
Gonzales et al., “Maca (
[cited by applicant]
Gonzales et al., “Red maca (
[cited by applicant]
Gonzales, “Effect of Black maca (
[cited by applicant]
Gonzales, “Ethnobiology and Ethnopharmacology of
[cited by applicant]
Gonzales-Arimborgo et al., “Acceptability, Safety, and Efficacy of Oral Administration of Extracts of Black or Red Maca (
[cited by applicant]
Gonzales-Castañeda et al., “Photoprotection against the UVB-induced oxidative stress and epidermal damage in mice using leaves of three different varieties of
[cited by applicant]
Incaliving Corp., Triple Maca Powder—100 Vegetable Capsules by Incaliving ( Red, Black and Yellow Maca) * 100% USDA Organic * 100% Gelatinized * 500mg per Capsule* Authentic Peruvian Maca, Website on Amazon.com, Inc., […
[cited by applicant]
Incaliving Corp., web archive, list of maca products, [online], [Copyright 2018]. Retrieved from the Internet: <URL: https://web.archive.org/web/20210613085358/https://www.incalivingshop.com/macaproductpage/>.
[cited by applicant]
Incaliving Corp., web archive, product page of “Premium Triple Maca Powder” ,[online], [Copyright 2018]. Retrieved from the Internet: <URL: https://web.archive.org/web/20210613081153/https://www.incalivingshop.com/produ…
[cited by applicant]
Incaliving Corp., website, article entitled “What You Need to Know About Maca!”, [online], [dated Dec. 15, 2013]. Retrieved from the Internet: <URL: https://incalivingshop.com/what-you-need-to-know-about-maca/>.
[cited by applicant]
International Search Report and Written Opinion issued in related Application No. PCT/US17/58166, mailed May 8, 2018.
[cited by applicant]
Li et al., “Glucosinolate Contents In Maca (
[cited by applicant]
Maca black and red purple, [online], [dated 2015]. Retrieved from the Internet: <URL: https://www.pureformulas.com/maca-x-6-powder-black-red-purple-61-raw-gelatinized-53-oz-by-organic-traditions.html>.
[cited by applicant]
Meissner et al., “Hormone-Balancing Effect of Pre-Gelatinized Organic Maca (Lepidium peruvianum Chacon): (II) Physiological and Symptomatic Responses of Early-Postmenopausal Women to Standardized doses of Maca in Double…
[cited by applicant]
Meissner et al., “Hormone-Balancing Effect of Pre-Gelatinized Organic Maca (Lepidium peruvianum Chacon): (III) Clinical responses of early-postmenopausal women to Maca in double blind, randomized, Placebo-controlled, cr…
[cited by applicant]
Meissner et al., “Peruvian Maca (
[cited by applicant]
Mintel, [online], “Maca Powder”, (Feb. 29, 2016). Retrieved from the Internet: <URL: www.gnpd.com>.
[cited by applicant]
Mintel, [online], “Premium Maca Powder”, (Jul. 17, 2012). Retrieved from the Internet: <URL: www.gnpd.com>.
[cited by applicant]
Monteghirfo et al., “Characterization of three maca (
[cited by applicant]
Muhammad et al., “Maca (
[cited by applicant]
Piacente et al., “Investigation of the Tuber Constituents of Maca (
[cited by applicant]
Purnomo et al., “Decoding Multiple Biofunctions of Maca on its Anti-allergic, Anti-inflammatory, Anti-thrombotic, and Pro-angiogenic Activities,” J. Agric. Food Chem., 2021; 69: pp. 11856-11866.
[cited by applicant]
Ramírez, “ Biotechnology and Secondary Metabolitos in
[cited by applicant]
Raskin et al., “Can an Apple a Day Keep the Doctor Away?” Current Pharmaceutical Design, 2004; 10: pp. 3419-3429.
[cited by applicant]
Rubio et al., “Effect of three different cultivars in
[cited by applicant]
SelvaBio Ltd., Triple Maca root Organic and Gelatinized. [online], 2012. Available in https://www.selvabio.com/gb/maca-root/1-triple-maca-root-organic-gelatinized-0784927218297.html.
[cited by applicant]
Sun et al., Composition analysis and antioxidant activity of essential oils, lipids and polysaccharides in different phenotypes of
[cited by applicant]
Supplementary Partial European Search Report issued in related application No. EP 17864663, dated May 5, 2020.
[cited by applicant]
Tallarida, “Quantitative Methods for Assessing Drug Synergism,” Genes & Cancer, 2011; 2(11): pp. 1003-1008.
[cited by applicant]
The Maca Team, “Black Maca—How it's different and why to try it,” [online], 2014, [retrieved on Oct. 25, 2017]. Retrieved from the Internet: <URL: https://www.themacateam.com/black-maca-how-its-different-and-why-to-try-…
[cited by applicant]
Third Party Observations filed with the Australian Patent Office in AU Application No. 2017347805, mailed May 28, 2020.
[cited by applicant]
Third Party Observations filed with WIPO in PCT/US2017/058166, mailed Oct. 1, 2018.
[cited by applicant]
Yakuzen Scientific Research Institute Bulletin, 2013, vol. 6, pp. 13-27. (English translation of abstract and relevant information provided).
[cited by applicant]
Yang et al., “Effects of macamides on endurance capacity and anti-fatigue property in prolonged swimming mice”, Pharmaceutical Biology, 2015; 54(5): pp. 827-834.
[cited by applicant]
Zheng et al., “Effect of a lipidic extract from
[cited by applicant]
Zheng et al., “Lepidium meyenii Walp Exhibits Anti-Inflammatory Activity against ConA-Induced Acute Hepatitis,” Mediators of Inflammation, 2018; vol. 2018: pp. 1-11.
[cited by applicant]
U.S. Appl. No. 17/214,314, filed Mar. 26, 2021, James R. Komorowski et al.
[cited by applicant]
U.S. Appl. No. 16/201,057, filed Nov. 27, 2018, now U.S. Pat. No. 11,752,186, Sep. 12, 2023, James R. Komorowski et al.
[cited by applicant]
U.S. Appl. No. 16/121,054, filed Sep. 4, 2018, now U.S. Pat. No. 10,967,026, Apr. 6, 2021, James R. Komorowski et al.
[cited by applicant]
U.S. Appl. No. 15/785,170, filed Oct. 16, 2017, now U.S. Pat. No. 10,183,049, Jan. 22, 2019, James R. Komorowski et al.
[cited by applicant]
U.S. Appl. No. 15/654,440, filed Jul. 19, 2017, now U.S. Pat. No. 10,265,364, Apr. 23, 2019, James R. Komorowski et al.
[cited by applicant]
PCT/US2017/058166, Oct. 24, 2017, James R. Komorowski et al.
[cited by applicant]
U.S. Appl. No. 62/411,977, filed Oct. 24, 2016, James R. Komorowski et al.
[cited by applicant]
U.S. Appl. No. 15/654,440, dated Apr. 27, 2018, Notice of Allowance in the U.S. Patent and Trademark Office.
[cited by applicant]
U.S. Appl. No. 15/654,440, dated Sep. 12, 2018, Corrected Notice of Allowability in the U.S. Patent and Trademark Office.
[cited by applicant]
U.S. Appl. No. 15/654,440, dated Mar. 7, 2019, Notice of Allowance in the U.S. Patent and Trademark Office.
[cited by applicant]
U.S. Appl. No. 15/785,170, dated Aug. 30, 2018, Notice of Allowance in the U.S. Patent and Trademark Office.
[cited by applicant]
U.S. Appl. No. 15/785,170, dated Dec. 19, 2018, Corrected Notice of Allowability in the U.S. Patent and Trademark Office.
[cited by applicant]
U.S. Appl. No. 16/121,054, dated Aug. 19, 2020, Notice of Allowance in the U.S. Patent and Trademark Office.
[cited by applicant]
U.S. Appl. No. 16/201,057, dated May 24, 2023, Notice of Allowance in the U.S. Patent and Trademark Office.
[cited by applicant]
U.S. Appl. No. 17/214,314, dated Jul. 18, 2024, Notice of Allowance in the U.S. Patent and Trademark Office.
[cited by applicant]
U.S. Appl. No. 17/214,314, dated Oct. 15, 2024, Notice of Allowance in the U.S. Patent and Trademark Office.
[cited by applicant]